Low doses of propofol have been shown to inhibit pancreatic cancer cell proliferation, migration, and invasion by downregulating ADAM8 expression, an effect mediated by the suppression of specificity protein 1 (SP1), which regulates ADAM8 transcription. The gene discussed is SP1; the disease is pancreatic neoplasm.